CN107163124A - Applications of the SPNP IX in Nav1.3 channel inhibitors are prepared - Google Patents
Applications of the SPNP IX in Nav1.3 channel inhibitors are prepared Download PDFInfo
- Publication number
- CN107163124A CN107163124A CN201710478447.3A CN201710478447A CN107163124A CN 107163124 A CN107163124 A CN 107163124A CN 201710478447 A CN201710478447 A CN 201710478447A CN 107163124 A CN107163124 A CN 107163124A
- Authority
- CN
- China
- Prior art keywords
- spider
- sodium
- sodium channel
- suppression
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Insects & Arthropods (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention discloses a kind of application process of biologically active polypeptide in voltage-gated sodium channel tool reagent Nav1.3 types sodium channel inhibitor is prepared, described biologically active polypeptide is spider suppression sodium peptide IX（SPNP‑IX）, the verification experimental verification active peptides have obvious inhibitory action to Nav1.3 type voltage-gated sodium channels.When preparing voltage-gated sodium channel hypotype tool molecule, it is 1 μm of ol/L and 5 μm of ol/L to prepare the concentration of cell external administration.Concentration compliance is presented in suppression of the SPNP IX to Nav1.3 types sodium channel, is a kind of preferable Nav1.3 types sodium channel tool reagent.
Description
Technical field
The present invention relates to a kind of purposes of active peptides in ion channel tool reagent is prepared, chemical legal system is especially used
Standby Guangxi tassel hair spider Toxic extraction thing-spider suppression sodium peptide-IX（It is abbreviated as SPNP-IX）Preparing voltage-gated sodium channel instrument
Purposes in the inhibitor of reagent-Nav1.3 types sodium channel.
Background technology
Voltage-gated sodium channel is distributed widely in the excitabilities such as neuron, cardiac muscle, vascular smooth muscle, pancreas, skeletal muscle
A kind of important transmembrane structure albumen in tissue, its participate in regulation secretion of neurotransmitter, vessel retraction, pancreatic secretion and
One of the various physiological processes such as skeletal muscle excitability, while be also the important target of medicine effect.Sodium channel is in action electricity
Key effect in the generation and communication process of position, voltage-gated sodium channel turns into the action target of many animals and plants toxin.
The structure-function relationship research of sodium-ion channel has become international study hotspot.Voltage-gated sodium channel is likely into
For the critical treatment target spot of the diseases such as nerve and angiocarpy.The zootoxin of nature be a class have very high practical value and
The tool reagent or drug targeting material of application prospect, are not only the powerful mean that venomous animal resists natural enemy, are also to be engaged in god
Valuable materials through biology and Physiologic Studies, the exploitation of natural original new drug and protein basic research, while being also to grind
Study carefully the uniqueness " molecular probe and decipher " of ion channel.So far, from many animals（As scorpion, spider, snake and ocean are dynamic
Thing etc.）Venom in identified the active components of many batrachotoxins.They pass through the diverse location phase with sodium channel
Occur corresponding change with reference to so as to the dynamic characteristic for causing passage, such as passage de-inactivation, passage mouthful, easyization activate,
Inactivation delays.By illustrating the molecular mechanism of these specific modulator batrachotoxins, except that can go deep into theory
Speculate outside functional activity difference and the gate active mechanism between the hypotype of sodium channel, can also be that they are developed into the treatment mankind
The new drug of relevant disease provides sufficient theoretical foundation and wide application prospect.
The content of the invention
It is contemplated that in provide a kind of Guangxi tassel hair spider Toxic extraction thing-spider suppression sodium peptide-IX prepare it is valtage-gated
Application in the inhibitor of sodium channel tool reagent-Nav1.3 types sodium channel, described Guangxi tassel hair spider Toxic extraction thing-spider suppression
Sodium peptide-IX（It is abbreviated as SPNP-IX）, its amino acid sequence is：
NH2-Glu Cys Thr Lys Leu Leu Gly Gly Cys Thr Lys Asp Ser Glu Cys Cys Pro
His Leu Gly Cys Arg Lys Lys Trp Pro Tyr His Cys Gly Trp Asp Gly Thr Phe-
NH2
It is characterized in that Guangxi tassel hair spider Toxic extraction thing-spider suppression sodium peptide-IX is used to prepare as single effective active component
Nav1.3 types sodium channel inhibitor.
A kind of described Guangxi tassel hair spider Toxic extraction thing-spider suppression sodium peptide-IX is preparing voltage-gated sodium channel instrument
Application in the inhibitor of reagent-Nav1.3 types sodium channel, it is characterised in that described spider suppression sodium peptide-IX N-terminal the 2nd half
Between cystine and the 16th cysteine, between the 9th cysteine of N-terminal and the 21st cysteine, the 15th half Guang of N-terminal
Disulfide bond is formed respectively between propylhomoserin and the 29th cysteine.
The spider presses down sodium peptide-IX and is used to prepare Nav1.3 types sodium channel inhibitor as single effective active component, with thin
The mode of extracellular administration is prepared into Nav1.3 types sodium channel tool reagent.
Spider presses down sodium peptide-IX when preparing Nav1.3 types sodium channel tool reagent or inhibitor, prepares cell external administration
Dosage is 1 μm of ol/L.
Spider presses down suppression of the sodium peptide-IX to Nav1.3 types sodium channel and concentration dependent is presented, and is a kind of preferable Nav1.3
Type sodium channel tool reagent.
Brief description of the drawings
Fig. 1 is influences of the SPNP-IX to Nav1.3 types sodium channel.
Embodiment
It is of the invention with more abundant disclosure in order to be better understood from, below will be by extracellular method of administration, using transfection
HEK293T cell models illustrate spider suppression sodium peptide-IX Nav1.3 types sodium channel inhibitory action.
1st, experiment material and method
1.1 human embryonic kidney cells（HEK293T）Culture and transfection
The cell adapted sour environments of HEK293T, pH values at 6.9~7.1, can smooth adherent growth, action will when changing liquid
Gently.The general DMEM culture mediums with high sugar.
1.1.1 the Secondary Culture of cell
(1) HEK293 passages opportunity, to converge up to 80-90%, after cell is covered with 60mm culture dishes, sops up culture
Liquid.
(2) add appropriate PBS rinsings twice, sop up.
(3) add the pancreatin of 0.5mL 0.25%, shake up.Pancreatin handles 2-3min in 37 DEG C of incubators.In micro- Microscopic observation
Whether cell all takes off wall.Add appropriate 10% NBCS DMEM nutrient solutions and terminate pancreatin reaction.
(4) cell mass is gently inhaled with pipette and breaks into individual cells.Cell is averagely divided into equipped with preheating training by 1: 3
In the culture dish of nutrient solution, in 37 DEG C, 5% CO2, cultivate in 15% relative humidity incubator.
1.1.2 the liposome transfection method of cationic:
（1）In the day before transfection, for 35mm culture dishes, the nutrient solution culture of antibiotic is free of with 2mL per ware.
（2）The same day of transfection, cell density is preferably up to 80-90%, sops up old nutrient solution, and PBS is rinsed once, changes 2mL into
Serum-free opti-MEM nutrient solutions.
（3）It is 4 μ g per ware DNA consumptions, is diluted to 250 μ L respectively with serum-free serum-free opti-MEM nutrient solutions, gently
Mix, be stored at room temperature 5min.
（4）10 μ L liposomes are added in 250 μ L serum-free opti-MEM nutrient solutions simultaneously, gently mixes, is stored at room temperature
5min。
（5）The liposome of dilution is added into isometric DNA to mix, 20min is stored at room temperature.
（6）0.5mLDNA/ liposome complexes are gently mixed, are added dropwise in cell, are gently mixed, normal condition training
Support.
（7）DNA/ liposome complexes are allowed with after cells contacting 4-6h, changing the training of 10% NBCS DMEM nutrient solutions into
Support.Patch clamp experiments can be carried out in 24-72h.
1.2 patch-clamp electrophysiologic activity is tested
Patch clamp experiments are in room temperature（25±1℃）Carry out, using whole-cell patch-clamp recording technique.Select the smooth visible, born of the same parents of plasma membrane
Matter uniformly has the HEK293T cells of green fluorescence as experimental cell.Electric current record is utilized by whole-cell patch-clamp recording technique
EPC9 amplifiers (HEKA companies, German) are carried out on computers.Computer recording and analysis system use Pulse+
The softwares of Pulsefit 8.0.Vitreous electricity pole pipe is borosilicate glass capillary tube（Nanjing spring teaching experiment equipment factory）.Glass
The step of electrode two draws and formed, and eletrode tip diameter is about 3 μm after polished instrument (Narishige, Japan) polishing, charges electrode
Electrode resistance is 1-3M Ω after liquid.Patch clamp experiments will be carried out at ambient temperature, and the variation of temperature is most in whole experiment process
It is many to be no more than 2 DEG C up and down.Using the software analysis experimental results of SigmaPlot 9.0.
2nd, experimental result and analysis
Influences of 2.1 SPNP-IX to Nav1.3 type voltage-gated sodium channels
With whole-cell patch-clamp recording technique, we further study sodium of the SPNP-IX to transient expression in HEK293T cells and lead to
Road hypotype Nav1.3 inhibitory action.Sodium channel hypotype electric current is induced in same depolarising mode：Cell membrane potential is clamped down on
In -80 mV, a test voltage -10mV is given with 50 ms time-histories, is repeated once every 5 s.
As shown in figure 1,1 μM, 5 μM and 10 μM SPNP-IX has certain inhibitory action to Nav1.3 passages, it presses down
Processing procedure degree is respectively 31%, 54% and 68%.SPNP-IX also has an impact to the inactivation of Nav1.3 passages, can substantially delay Nav1.3 sodium
The inactivation of passage.SPNP-IX is to the suppression of Nav1.3 passages and delays deactivation that obvious concentration compliance is presented.
SEQUENCE LISTING
<110>Changsha Qin Cai bio tech ltd
<120>Spider suppression sodium peptide-IX
<160> 1
<170> PatentIn version 3.3
<210> 1
<211> 35
<212> PRT
<213>Guangxi tassel hair spider
<400> 1
Glu Cys Thr Lys Leu Leu Gly Gly Cys Thr Lys Asp Ser Glu Cys
1 5 10 15
Cys Pro His Leu Gly Cys Arg Lys Lys Trp Pro Tyr His Cys Gly
16 20 25 30
Trp Asp Gly Thr Phe
31
Claims (5)
1. a kind of Guangxi tassel hair spider Toxic extraction thing-spider suppression sodium peptide-IX is preparing sodium channel tool reagent-Nav1.3 sodium channels
Application in inhibitor, described Guangxi tassel hair spider Toxic extraction thing-spider suppression sodium peptide-IX（It is abbreviated as SPNP-IX）, its amino
Acid sequence is：
NH2-Glu Cys Thr Lys Leu Leu Gly Gly Cys Thr Lys Asp Ser Glu Cys Cys Pro
His Leu Gly Cys Arg Lys Lys Trp Pro Tyr His Cys Gly Trp Asp Gly Thr Phe-
NH2
It is characterized in that Guangxi tassel hair spider Toxic extraction thing-spider suppression sodium peptide-IX is used to prepare as single effective active component
Nav1.3 types sodium channel inhibitor.
2. application process according to claim 1, it is characterised in that spider suppression sodium peptide-IX is used as single effective active group
Dividing is used to prepare Nav1.3 types sodium channel inhibitor.
3. application process according to claim 1, it is characterised in that spider suppression sodium peptide-IX is prepared into cell external administration
Nav1.3 types sodium channel tool reagent.
4. application process according to claim 1, it is characterised in that spider presses down sodium peptide-IX and led in preparation Nav1.3 types sodium
When road tool reagent or inhibitor, it is 1 μm of ol/L and 5 μm of ol/L to prepare the dosage of cell external administration.
5. application process according to claim 1, it is characterised in that concentration dependant is presented in spider suppression sodium peptide-IX suppression
Property.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710478447.3A CN107163124A (en) | 2017-06-22 | 2017-06-22 | Applications of the SPNP IX in Nav1.3 channel inhibitors are prepared |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710478447.3A CN107163124A (en) | 2017-06-22 | 2017-06-22 | Applications of the SPNP IX in Nav1.3 channel inhibitors are prepared |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107163124A true CN107163124A (en) | 2017-09-15 |
Family
ID=59819084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710478447.3A Pending CN107163124A (en) | 2017-06-22 | 2017-06-22 | Applications of the SPNP IX in Nav1.3 channel inhibitors are prepared |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107163124A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011033358A2 (en) * | 2009-09-15 | 2011-03-24 | Biosearch (2007) Ltd | Novel peptides isolated from spider venom, and uses thereof |
| CN105753957A (en) * | 2016-04-20 | 2016-07-13 | 长沙沁才生物科技有限公司 | Application of polypeptide in preparation of Nav1.4 sodium channel inhibitors |
-
2017
- 2017-06-22 CN CN201710478447.3A patent/CN107163124A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011033358A2 (en) * | 2009-09-15 | 2011-03-24 | Biosearch (2007) Ltd | Novel peptides isolated from spider venom, and uses thereof |
| CN105753957A (en) * | 2016-04-20 | 2016-07-13 | 长沙沁才生物科技有限公司 | Application of polypeptide in preparation of Nav1.4 sodium channel inhibitors |
Non-Patent Citations (2)
| Title |
|---|
| 孙娟等: "《心肌细胞离子通道电生理学研究》", 30 September 2015, 华中科技大学出版社 * |
| 邓梅春: "敬钊缨毛蛛毒素与虎纹捕鸟蛛毒素的结构与功能研究", 《中国博士学位论文全文数据库•医药卫生科技辑》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sirinupong et al. | Crystal structure of cardiac-specific histone methyltransferase SmyD1 reveals unusual active site architecture | |
| Sun et al. | The crystal structure of a multifunctional protein: phosphoglucose isomerase/autocrine motility factor/neuroleukin | |
| Nguyen et al. | Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities | |
| Whiteaker et al. | Discovery, synthesis, and structure activity of a highly selective α7 nicotinic acetylcholine receptor antagonist | |
| Buczek et al. | Post-translational amino acid isomerization: a functionally important D-amino acid in an excitatory peptide | |
| Kakuta et al. | Crystal structure of Escherichia coli Fdx, an adrenodoxin-type ferredoxin involved in the assembly of iron− sulfur clusters | |
| Sawaya et al. | Structures of cytochrome c-549 and cytochrome c 6 from the cyanobacterium Arthrospira maxima | |
| CN107163126A (en) | Applications of the SPNP I in Nav1.7 passage tool reagents are prepared | |
| Devkota et al. | Engineering broad-spectrum inhibitors of inflammatory chemokines from subclass A3 tick evasins | |
| CN107163124A (en) | Applications of the SPNP IX in Nav1.3 channel inhibitors are prepared | |
| CN107163117A (en) | A kind of application of polypeptide in Nav1.3 sodium channels tool reagent is prepared | |
| CN107163121A (en) | Applications of the SPNP 27 in Nav1.5 channel inhibitors are prepared | |
| CN107176985A (en) | Applications of the SPNP 27 in Nav1.7 channel inhibitors are prepared | |
| CN107163120A (en) | Applications of the SPNP 27 in Nav1.3 channel inhibitors are prepared | |
| CN107226851A (en) | Applications of the SPNP I in Nav1.5 passage tool reagents are prepared | |
| CN107176986A (en) | Applications of the SPNP I in Nav1.3 passage tool reagents are prepared | |
| CN107163125A (en) | Applications of the SPNP I in Nav1.2 passage tool reagents are prepared | |
| CN107163127A (en) | Applications of the SPNP I in Nav1.4 passage tool reagents are prepared | |
| CN107163123A (en) | Applications of the SPNP IX in Kv4.2 passage tool reagents are prepared | |
| CN107163122A (en) | Applications of the SPNP IX in Kv4.3 passage tool reagents are prepared | |
| CN107337722A (en) | Applications of the SPKP 35 in Nav1.5 channel inhibitors are prepared | |
| CN107226852A (en) | SPNP III are preparing the application of Nav1.5 channel inhibitors | |
| CN107056917A (en) | A kind of application of polypeptide in Nav1.5 passage tool reagents are prepared | |
| Herzig et al. | The tarantula toxin ω-Avsp1a specifically inhibits human CaV3. 1 and CaV3. 3 via the extracellular S3-S4 loop of the domain 1 voltage-sensor | |
| CN105833247A (en) | Application of polypeptide to prepare KV2.1-type potassium channel tool reagent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170915 |
|
| WD01 | Invention patent application deemed withdrawn after publication |